Q1C: Stability Testing for New Dosage Forms

Regulatory Resource: Q1C: Stability Testing for New Dosage Forms

Description:

The tripartite harmonised ICH guideline was finalised (Step 4) in November 1996. It extends the main stability guideline for new formulations of already approved medicines and defines the circumstances under which reduced stability data can be accepted.

Download Document: Q1C: Stability Testing for New Dosage Forms

0.09 Megabytes